Events

Search Language

日本語 / Japanese | Use language selector above (below, on mobile) to search additional languages

128 items matching filters

Events

Tech Communications Day

June.17.2023 | Orrick Düsseldorf

Joint event on (crisis) communication for tech companies by RWTH Entrepreneurship Center and WHU Entrepreneurship Center, supported by Orrick

Events

Sifted Sessions Berlin

May.25.2023 | Vollgutlager, Berlin

Sifted Sessions spotlights Europe's leading startups, scaleups & investors in unique spaces. Connecting the who's who with the who's next.

Events

Deep Tech Momentum 2023

May.24.2023 - May.27.2023 | DAS LIEBIG, Aachen

Multi-day Deep Tech Momentum by RWTH Aachen university and Techstars Berlin supports the European deep tech ecosystem

Events

ATEC - Aachen Tech Conference

May.24.2023 | DAS LIEBIG

10+ yrs celebrating entrepreneurship & tech by uniting innovators, entrepreneurs & decision makers from business, politics & academia.

Events

Microsoft Ready Set Scale - FinTech

March.02.2023 |

Sven Greulich, Cameron Carr, Kelly Hagedorn, Joseph Santiesteban will be speaking about common founder mistakes and leveraging cybersecurity to scale.

Events

Microsoft Ready Set Scale - FinTech

February.14.2023 |

Sven Greulich, Cameron Carr, Kelly Hagedorn, Joseph Santiesteban will be speaking about common founder mistakes and leveraging cybersecurity to scale.

Events

Total Access Japan:新年会

January.26.2023 |

会の前半においてはオリック・シリコンバレー・オフィスのジョセフ・パーキンス米国弁護士による、「シリコンバレーにおけるベンチャー・キャピタルやスタートアップ企業の最新動向」と題したショート・プレゼンテーションを行う予定です。

Events

Founder Legal Boot Camp #3

November.12.2022 - November.13.2022 | Orrick Düsseldorf or Remote via Zoom

The third edition of Orrick’s Founder Legal Boot Camp – together with RWTH Innovation, WHU Entrepreneurship Center and TUM Venture Labs.

Events

Are there still opportunities in China and Asia for US biopharmas?

October.19.2022 | Orrick New York

China is the second largest pharmaceutical market in the world, growing to $205bn by 2026. With an increasing focus on innovation and early access, many US biopharmas have found that an anchor in China supports accelerated clinical development and creates incremental value via either through equity ...